ABT Molecular Imaging is a medical imaging company marketing its Generator, a production platform which produces unit doses of molecular imaging drugs for positron emission tomography (PET) at the point of use, eliminating the need for chemistry and physics expertise. The company was founded in 2006 by industry experts in the molecular imaging industry.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/14/12 | $6,000,000 | Series C |
Council Capital Intersouth Partners Mountain Group Capital River Cities Capital Funds | undisclosed |
